CARGO Therapeutics Inc. C... (CRGX)
NASDAQ: CRGX
· Real-Time Price · USD
4.54
0.08 (1.79%)
At close: Aug 15, 2025, 3:59 PM
4.54
-0.11%
After-hours: Aug 15, 2025, 04:04 PM EDT
CARGO Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 |
Cash & Equivalents | 107.75M | 61.77M | 64.38M | 71.18M | 153.58M | 81.53M | 405.73M | 60.34M | 42.37M | 1.87M |
Short-Term Investments | 144.82M | 257.07M | 275.32M | 333.67M | 289.9M | 294.39M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 12.44M | 28.39M | n/a | 567K | 567K | 567K | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 660K | 5.88M | 5.22M | 4.38M | 4.38M | 4.39M | 7.02M | 4.43M | 783K |
Receivables | 802K | 1.42M | 2.04M | 2.87M | 2.52M | 2.42M | 1.74M | 475K | 475K | 476K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.88M | n/a |
Other Current Assets | 1.05M | 1.57M | n/a | n/a | n/a | n/a | n/a | n/a | 2.02M | n/a |
Total Current Assets | 258.61M | 324.81M | 345.01M | 410.02M | 448.1M | 379.95M | 409.48M | 63.42M | 46.74M | 3.93M |
Property-Plant & Equipment | n/a | 24.05M | 34.78M | 35.72M | 36.97M | 37.53M | 38.6M | 11.97M | 9.32M | 5.53M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | 37.15M | 69.04M | 40.94M | 41.92M | 42.48M | 43.56M | 19M | 13.76M | 6.32M |
Total Assets | 258.61M | 361.96M | 414.05M | 450.96M | 490.01M | 422.43M | 453.04M | 82.41M | 60.5M | 10.24M |
Account Payables | 8.67M | 4.23M | 2.44M | 5.37M | 7.01M | 7.17M | 5.01M | 7.43M | 5.82M | 3.48M |
Deferred Revenue | n/a | n/a | n/a | n/a | -14.53M | 12.29M | n/a | n/a | 8.73M | 4.65M |
Short-Term Debt | n/a | n/a | n/a | n/a | 649K | 1.64M | 2.28M | 20.16M | n/a | 21.91M |
Other Current Liabilities | 739K | 2.24M | 9.27M | 16.13M | 18.77M | -1.8M | 4.14M | 1.16M | 12.49M | 15.47M |
Total Current Liabilities | 20.91M | 51.55M | 25.03M | 21.64M | 26.42M | 22.65M | 21.16M | 41.13M | 28.11M | 44.14M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 225K | 150.31M | 106.39M | 250K |
Total Long-Term Liabilities | n/a | 27.95M | 28.8M | 28.44M | 27.49M | 26.57M | 26.49M | 150.61M | 107.37M | 1.34M |
Total Liabilities | 20.91M | 79.5M | 53.83M | 50.08M | 53.91M | 49.22M | 47.65M | 191.75M | 135.48M | 45.48M |
Total Debt | 578K | 30.45M | 29.43M | 28.58M | 28.14M | 28.2M | 28.54M | 2.89M | 3.47M | 24M |
Common Stock | 46K | 46K | 46K | 46K | 46K | 39K | 41K | 1K | 15K | 15K |
Retained Earnings | -447.08M | -397.15M | -312.65M | -267.21M | -225.31M | -180.96M | -145.15M | -113.07M | -77.6M | -47M |
Comprehensive Income | -9K | 96K | 291K | 635K | -323K | -279K | n/a | n/a | n/a | n/a |
Shareholders Equity | 237.7M | 282.46M | 360.23M | 400.88M | 436.1M | 373.21M | 405.39M | 40.75M | -74.98M | -35.24M |
Total Investments | 144.82M | 269.51M | 303.71M | 333.67M | 290.46M | 294.39M | 567K | n/a | n/a | n/a |